Skip to main content
Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
7.45
-0.37 (-4.73%)
Dec 20, 2024, 4:00 PM EST - Market closed

Phathom Pharmaceuticals Revenue

Phathom Pharmaceuticals had revenue of $16.35M in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to $26.27M. In the year 2023, Phathom Pharmaceuticals had annual revenue of $682.00K.

Revenue (ttm)
$26.27M
Revenue Growth
n/a
P/S Ratio
16.94
Revenue / Employee
$58,119
Employees
452
Market Cap
509.41M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023682.00K--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Auna S.A. 1.17B
Xeris Biopharma Holdings 187.36M
Talkspace 181.29M
Semler Scientific 58.94M
Sangamo Therapeutics 52.29M
Cartesian Therapeutics 47.94M
EyePoint Pharmaceuticals 45.71M
CorMedix 12.26M
Revenue Rankings

PHAT News

More News